DNA methylation age is an accurate biomarker of chronological age and predicts lifespan, but its underlying molecular mechanisms are unknown. In this genome-wide association study of 9,907 individuals, we found gene variants mapping to five loci associated with intrinsic epigenetic age acceleration (IEAA) and gene variants in 3 loci associated extrinsic epigenetic age acceleration (EEAA). Mendelian randomization analysis suggested causal influences of menarche and menopause on IEAA and lipid levels on IEAA and EEAA. Variants associated with longer leukocyte telomere length (LTL) in the telomerase reverse transcriptase gene (TERT) locus at 5p15.33 confer higher IEAA (P<2.7x10 -11 ). Causal modelling indicates TERT-specific and independent effects on LTL and IEAA. Experimental hTERT expression in primary human fibroblasts engenders a linear increase in DNA methylation age with cell population doubling number. Together, these findings indicate a critical role for hTERT in regulating the DNA methylation clock, in addition to its established role of compensating for cell replicationdependent telomere shortening. 5
Abstract
DNA methylation age is an accurate biomarker of chronological age and predicts lifespan, but its underlying molecular mechanisms are unknown. In this genome-wide association study of 9,907 individuals, we found gene variants mapping to five loci associated with intrinsic epigenetic age acceleration (IEAA) and gene variants in 3 loci associated extrinsic epigenetic age acceleration (EEAA). Mendelian randomization analysis suggested causal influences of menarche and menopause on IEAA and lipid levels on IEAA and EEAA. Variants associated with longer leukocyte telomere length (LTL) in the telomerase reverse transcriptase gene (TERT) locus at 5p15.33 confer higher IEAA (P<2.7x10 -11 ). Causal modelling indicates TERT-specific and independent effects on LTL and IEAA. Experimental hTERT expression in primary human fibroblasts engenders a linear increase in DNA methylation age with cell population doubling number. Together, these findings indicate a critical role for hTERT in regulating the DNA methylation clock, in addition to its established role of compensating for cell replicationdependent telomere shortening.
INTRODUCTION
DNA methylation (DNAm) profiles of sets of cytosine phosphate guanines (CpGs) allow one to develop accurate estimators of chronological age which are referred to as "DNAm age", "epigenetic age", or the "epigenetic clock". Across the life course the correlation between DNAm age and chronological age is greater than 0.95 1, 2 . Individuals whose leukocyte DNAm age is older than their chronological age ("epigenetic age acceleration") display a higher risk of allcause mortality after accounting for known risk factors [3] [4] [5] [6] , and offspring of centenarians exhibit a younger DNAm age 7 . Taken together, these findings suggest that DNAm age is a biomarker of biological age -a premise supported by associations of epigenetic age acceleration with cognitive impairment, neuro-pathology in the elderly 8, 9 , Down syndrome 10 , Parkinson's disease 11 , obesity 12 , HIV infection 13 , and frailty 14 , and menopause 15 . However, DNAm age shows no apparent correlation with telomere length, whose pace of shortening in cultured somatic cells has been referred to as the 'mitotic clock'. In vivo, DNAm age and telomere length appear to be independent predictors of mortality 16 .
Here, we examine two widely used measures of epigenetic age acceleration: (a) intrinsic epigenetic age acceleration (IEAA), based on 353 CpGs described by Horvath (2013) 2 , which is independent of age-related changes in blood cell composition, and (b) extrinsic epigenetic age acceleration (EEAA), an enhanced version of that based on 71 CpGs described by Hannum (2013) which up-weights the contribution of blood cell count measures 1, 6 . IEAA and EEAA are only moderately correlated (r=0.37) 17 . IEAA measures cell-intrinsic methylation changes, exhibits greater consistency across different tissues, appears unrelated to lifestyle factors and probably indicates a fundamental cell ageing process that is largely conserved across cell types 2, 6 . By contrast, EEAA captures age-related changes in leukocyte composition and correlates with lifestyle 17 , yielding a stronger predictor of all-cause mortality 6 . To understand mechanisms that explain DNAm age, we performed genome-wide association studies (GWAS) of IEAA and EEAA based on leukocyte DNA samples from almost ten thousand individuals.
RESULTS

GWAS meta-analyses for IEAA and EEAA
Genomic analyses were performed in as many as 9,907 individuals (aged 10-98 years), from 15 data sets, adjusted for chronological age and sex (Supplementary Table 1, Fig. 1 and Supplementary note 1). Eleven data sets comprised individuals of European ancestry (84.7%) and four comprised individuals of African (10.3%) or Hispanic ancestry (5.0%). GWAS genotypes were imputed to ~7.4 million variants using the 1000 genomes reference panel.
Heritability estimates based on family relationships in one European ancestry cohort were ݄ ூ ா ଶ =0.37 and ݄ ா ா ଶ =0.33, which are consistent with previous estimates in twins 2 and with those obtained in other tissues (e.g., adipose and brain) 12, 18, 19 Table 2 ).
We first performed GWAS meta-analysis of IEAA and EEAA only in our European ancestry cohorts (N= 8,393) . Variants with suggestive associations (P < 1.0x10 -5 ) were then evaluated in non-European ancestry cohorts (N= 1,514), followed by a combined meta-analysis across the two strata ( Fig. 1a&b) . We found no evidence for genomic inflation in individual studies 
Transcriptomic studies in leukocytes
To learn about potential functional consequences of these associations, we conducted cis-eQTL analysis for each locus associated with IEAA or EEAA, using data on leukocyte mRNA expression in up to 15,295 samples from five studies ( Fig. 1c; Methods) . We identified 11
putative cis-eQTLs located in seven of the eight associated loci ( Supplementary Tables 6 &7) .
Each putative cis-eQTL was then analyzed by summary data-based Mendelian randomization (SMR), which infers the association between gene transcript levels and the outcome trait 22 (Methods). Three transcripts were associated with IEAA: KPNA4 at 3q25.33, TPMT at 6p22.3 and STXBP4 at 17q22; and three transcripts were associated with EEAA: RNF4 at 4p16.3, and ZNF25 and HSD17B7P2 at 10p11.1 ( Table 2 and Supplementary Table 8 ). Notably, STXBP4, encoding the syntaxin binding protein, is a reported locus for age at menarche 23 , and our lead SNP for IEAA was also associated with age at menarche (rs78781855, P=0002). Consistent with our genetic analyses, blood transcript levels of several cis-acting genes correlate directly with chronological age, for example: STXBP4: r=-0.13, p=3x10 -9 ; RNF4: r=-0.09, p=1.0x10 -5 ; ZNF25:
r=0.06, p=6.4x10 -3 ( Supplementary Table 9 ). Additional details can be found in Supplementary note 3.
Alleles associated with higher IEAA at the TERT locus were also associated with longer telomere length
The TERT locus (in 5p15.33) harbored 11 genome-wide significant SNPs for IEAA but conditional analysis did not reveal any secondary signal ( Table 1, Fig. 3a , and Supplemental Table 5 ). The leading SNP, rs2736099, was located in a region transcribed in human embryonic stem cells, induced pluripotent stem cells, and hematopoietic stem cells ( Supplementary Fig.   8b ), and each minor allele conferred 0.6 years higher IEAA (P=1.3x10 -12 ; Table 1 , Supplementary Fig. 6b ). Our IEAA locus at TERT closely overlaps the reported GWAS locus for leukocyte telomere length (LTL [24] [25] [26] , Fig. 3b ). SMR analysis indicated that the association signals for LTL and IEAA at this TERT locus share the same underlying causal variant (as indicated by a non-significant HEIDI test, Supplementary Table 10 , Supplementary Fig. 11c ).
Intriguingly, TERT alleles associated with a longer LTL (indicative of younger biological age) were robustly associated with increased IEAA (indicative of older biological age) (P ~ 1.0x10 -11 , Table 3 , Supplementary Table 11 and Supplementary Figure 12 ).
Other known GWAS LTL signals (at 10q24.33 near OBFC1 and at 16q23.3 near MPHOSPH6), also exhibited modest associations with IEAA (4.1x10 -3 ≤ P ≤ 3.7x10 -2 ), but others such as the gene TERC (on 3q26.2) encoding the telomerase RNA component, showed no association ( Table 3 ). Using the lead variants for each trait in MR-Egger analyses 27 , we found pleiotropic effects specific to TERT on LTL and IEAA without evidence for a causal relation between LTL and IEAA (P =0.7, Table 4 and Supplementary Table 12 ).
IEAA-associated SNPs in the TERT locus also exhibit modest associations with epigenetic age acceleration in the prefrontal cortex (P < 0.05, Table 3 ). We found no association between LTLrelated SNPs and epigenetic age acceleration in other brain regions, which were represented by fewer brain samples ( Supplementary Table 13 ).
hTERT is required for DNAm ageing in human primary cells
As we were unable to functionally link IEAA to TERT through cis eQTL analysis at 5p15.33, we examined the effects of experimental-induced hTERT expression on IEAA in a primary human cell culture model. We introduced a TERT-expressing vector or empty vector (as control) into primary fibroblasts isolated from human neonatal foreskin. Transduced TERT-expressing and non-TERT cells were cultured in parallel. After reaching confluence, the cells were harvested, counted, seeded into fresh plates, and profiled using the Illumina Infinium 450K DNA methylation array.
While non-TERT cells senesced after ~150 days, TERT-expressing cells continued to proliferate unabated at a constant rate with the time in culture (Fig. 3c ). Single time point analyses ( Fig. 3d) showed that TERT-expressing cells exhibited a linear relationship between time in culture and the Horvath estimate of DNAm age (equivalent to a DNAm age of 50 years at 150 days), whereas in non-TERT cells DNAm age plateaued (equivalent to a DNAm age of 13 years) in spite of continued proliferation to the point of replicative senescence. Notably, DNAm age did not increase in TERT-expressing cells that received regular media change but were not passaged throughout the entire observation period of 170 days (right most bar in Fig. 3d ). These cells were not senescent, given that their subsequent passaging resulted in normal proliferation. In multivariable regression analysis, the associations of DNAm age with cell passage number and cell population doubling number were highly modified by TERT-expression (P-interaction:
P=1.6x10 -6 and P=4.0x10 -5 , respectively; Supplementary Table 14 ). In the absence of TERTexpression, DNAm age did not increase with cell passage number, cell population doubling number, or time in culture.
Other putative determinants of epigenetic age acceleration
To systematically elucidate possible further biological processes that influence epigenetic age acceleration, we tested our full genome-wide association statistics for IEAA and EEAA using a number of approaches. First, we used MAGENTA 28 (Methods) to identify biological pathways that are enriched for genes that harbor associated variants. For IEAA, nuclear transport (FDR=0.017), Fc epsilon RI signaling (FDR=0.027), and colorectal cancer processes (FDR=0.042) were implicated. For EEAA, mRNA elongation (FDR 0.011), mRNA transcription (FDR=0.018), and neurotrophin signaling pathway (FDR=0.042) were implicated ( Supplementary Table 15 ).
Second, we explored the genetic correlations ‫ݎ(‬ ) between IEAA or EEAA and several other phenotypes using LD score regression analysis of summary level GWAS data 29 (Methods and Fig. 1g ). We observed moderate positive genetic correlation between IEAA and EEAA ‫ݎ(‬ =0.5, ܲ =8.9x10 -3 ). IEAA showed weak positive genetic correlations with central adiposity (waist circumference; waist-to-hip ratio) and metabolic disease-related traits, and EEAA showed stronger positive genetic correlations with central adiposity ‫ݎ(‬ =0.27 with waist-to-hip ratio, P=8.0x10 -8 ) and metabolic disease-related traits ( Table 4 and Supplementary Table 16 ). IEAA and EEAA also showed modest inverse genetic correlations or trends with age at menopause.
Third, we performed MAGENTA based hypergeometric analyses to test whether the top 2.5% and 10% of genes enriched for GWAS associations with IEAA or EEAA overlap with the top enriched genes for a range of complex traits (Methods). This analysis suggested several additional possible genetic overlaps, including Huntington disease onset 30 and bipolar disorder with IEAA, schizophrenia with EEAA, and age-related dementia 18 with both IEAA and EEAA ( Supplementary Table 17 ).
Finally, all the study traits, were tested using MR-Egger which, by modelling the reported top genetic signals for each candidate trait, estimates the likely causal influence of that trait on IEAA or EEAA 27 (Methods). Nominally significant causal relationships on higher IEAA and EEAA were found for low density lipoprotein (LDL) and total cholesterol levels (P<0.05, Supplementary Tables 18 & 19 ) and for triglyceride levels on IEAA (P=3.0x10 -2 , Table 4 ).
Earlier menarche and menopause were associated with higher IEAA; each 1-year earlier age at menarche was associated +1.03 years higher IEAA (P=4.1x10 -3 ) and each 1-year earlier age at menopause was associated +0.43 years higher IEAA (P=3.5x10 -3 ) ( Table 4) .
DISCUSSION
This large genomic study provides several mechanistic insights into the regulation of epigenetic ageing, including apparently opposing roles for TERT on DNAm age and LTL. TERT encodes the catalytic subunit of telomerase, which counters telomere shortening during cell division 31 .
TERT also possesses activities unrelated to telomere maintenance, such as in DNA repair, cell survival, protection from apoptosis/necrosis, stimulation of growth [32] [33] [34] and cell proliferation, possibly by decreasing p21 production 35 . Here, we show an additional pleiotropic role of TERT on advancing cell intrinsic DNAm age during cell proliferation. Our findings provide an explanation for the previously reported rapid rate of DNAm ageing during embryonic development and early postnatal life, which are stages of rapid organismal growth accompanied by high levels of TERT activity and cell division 36 37,38 .
Our paradoxical finding that TERT alleles associated with longer telomeres are associated with higher IEAA is substantiated by our in vitro evidence that TERT expression promotes DNAm age; this might suggest a potential trade-off between telomere length and epigenomic maintenance systems. However, we found no evidence for a broader causal inter-relationship between telomere length and IEAA, consistent with the lack of phenotypic association between these traits in our studies (WHI: r = -0.05, p=0.16; FHS: r=0.0, p=0.99, ref 39 ) and in previous reports 14, 16 . Furthermore, while critically short telomere length is a well-established trigger of replicative senescence 36, [40] [41] [42] , the functional consequences of epigenetic ageing are yet unknown.
Our experimental data suggest that epigenetic ageing is not a determinant or marker of cell replicative senescence, since TERT-expressing cells continued to proliferate unabatedly despite well-advanced DNAm age, and non-TERT-expressing cells exhibited no DNAm age increase even at days 120-170 when proliferation had ceased. Rather, TERT suppression appears to allow cells to record their proliferation history during stages of development.
Large-scale cross-sectional cohort studies have previously reported associations between epigenetic age acceleration (IEAA and EEAA) and body mass index and measures of insulin resistance 17 . Our genetic correlation analyses (between the measures of age acceleration and complex phenotypes) indicate that some of these associations may arise in part from shared genetic variants. Moreover, our Mendelian randomization analyses provided tentative evidence for causal influences for blood lipid levels, but not for adiposity, on IEAA and EEAA.
Finally, we found evidence for causal influence of earlier ages at menarche and menopause on higher IEAA. The directionally-concordant influences of menarche and menopause, which signal the onset and cessation, respectively, of reproductive capacity, together with the lack of influence of any measure of adiposity on IEAA, suggest an effect of some yet identified driver of reproductive ageing on DNAm ageing. These findings, which suggests that sex steroids affect epigenetic ageing, are consistent with previously reported associations regarding early menopause timing and higher IEAA in blood 15 . While menopausal hormone therapy was not found to be associated with IEAA in blood, it was found to be associated with younger epigenetic age acceleration in buccal epithelium 15 . The effect of menopause is consistent with reported anti-ageing effects of sex hormone therapy on buccal cells and the pro-ageing effect of the surgical ovariectomy in blood 15 . Early age at menarche, a widely studied marker of the timing of puberty in females, is associated with higher risks for diverse diseases of ageing 43 . Our findings indicate epigenetic ageing as a possible intrinsic mechanism that underlies the recently described link between menarche age-lowering alleles and shorter lifespan 44 .
ONLINE METHODS
GWAS Cohorts
GWAS meta-analysis was performed on 9,907 individuals across 15 studies (Supplementary 
Estimating blood cell counts based on DNA methylation levels
We estimated blood cell proportions using two different software tools. Houseman's estimation method 46 , which is based on DNA methylation signatures from purified leukocyte samples, was used to estimate the proportions of cytotoxic (CD8+) T cells, helper (CD4+) T, natural killer, B
cells, and granulocytes. The software does not identify the type of granulocytes in blood (neutrophil, eosinophil, or basophil) but neutrophils tend to be the most abundant granulocyte (~60% of all blood cells compared with 0.5-2.5% for eosinophils and basophils). The advanced analysis option of our epigenetic age calculator software was used to estimate the percentage of exhausted CD8+ T cells (defined as CD28-CD45RA-) and the number (count) of naïve CD8+ T cells (defined as CD45RA+CCR7+) as described in Horvath et al. 13 These DNAm based estimates of blood cell counts are highly correlated with corresponding flow cytometric measures 47 .
GWAS meta-analysis
Our GWAS meta-analysis involved approximately 7.4 million SNPs/INDEL variants, which were genotyped and imputed markers with the 1000 genomes haplotype reference panel. Prior to imputation, SNP quality was assessed by estimating minor allele frequency (MAF), Hardy-Weinberg equilibrium (HWE), and missingness rates across individuals ( Supplementary Table   4 ). The individual studies used IMPUTE2 48, 49 with haplotypes phased using SHAPEIT 50 56 , and PLINK. All association models were adjusted for sex, to account for the higher epigenetic age acceleration in men than women 47 , and also for PCs as needed. We included variants with MAF ≥ 2%. SNPs were removed from an individual study if they exhibited extreme effects (absolute regression coefficient β >30, Supplementary Table 4 ).
We divided the meta-analysis into two since IEAA and EEAA differ across racial/ethnic groups 47 . In one arm, we performed GWAS meta-analysis of IEAA and EEAA, focusing on individuals of European ancestry (N= 8,393, studies 1-11 in Supplementary Table 1 ). We required a marker present in at least 5 study data sets and combined the coefficient estimates β from each study using a fixed-effects meta-analysis model weighted by inverse variance, as implemented in the software Metal 57 . In the other arm, each SNP with suggestive association (P < 1.0x10 -5 ) in
Europeans was subsequently evaluated in individuals of non-European ancestry (N= 1,514, studies 12-15 in Supplementary Table 1) . A further meta-analysis combined the GWAS findings from the two ancestries. We removed SNPs from the meta-analysis if they exhibited highly significant heterogeneity across studies (Cochran Q I 2 P-value ≤ 0.001), or (2) co-located with CpG from the DNAm age predictors according to the Illumina annotation file for the Illumina Infinium 450K array. We analyzed additional SNPs across all study sets to arrive at summary statistics at the combined stage, which were needed for our summary statistics based Mendelian randomization analyses. The quality of SNPs was also assessed using the Cochran Q I 2 P-value.
Linkage disequilibrium analysis
Regional SNP association results were visualized with the software LocusZoom 58 . All linkage disequilibrium (LD) estimates presented in this article were calculated using individuals of European ancestry from the 1000 genomes reference panel (released in Oct 2012).
Conditional analysis based on GCTA
The conditional analysis of the GCTA software [59] [60] [61] was used to test whether a given genetic locus harbored multiple independent causal variants. We conditioned on the leading SNP with the most significant meta-analysis P value ( for a significant trans-ethnic association.
Chromatin state annotations
For each leading SNP/variant of a significant locus, we used the UCSC genome browser to display the primary chromatin states across 127 cell/tissue lines at 200bp resolution ( Supplementary Fig. 8) . The n=127 diverse cell/tissue lines were profiled by the NIH RoadMap Epigenomics 21 (n=111) and ENCODE projects 62 (n=16). We used a 15-state chromatin model (from ChromHMM) which is based on five histone modification marks 21 .
Annotations for genome-wide significant variants
We used the HaploReg (version 4.1) tool 63 to display characters of genome-wide significant variants including conserved regions by GERP 64 and SiPhy 65 scores, DNase tracks, involved proteins and motifs, GWAS hits listed in NHGRI/EBI and functional annotation listed in dbSNP database, as summarized in Supplementary Table 5 .
Leucocyte cis-eQTL analyses
To evaluate cis-eQTL in blood, our cis-eQTL study leveraged a large-scale blood expression data (n=15,295) that came from five broad categories of data. The first category involved a largescale eQTL analysis in 5,257 individuals collected from the FHS pedigree cohort (of European ancestry) 66 . Linear mixed models were performed for the eQTL analysis, adjusted for family structure via random effects and adjusted gender, age, blood cell counts, PCs, and other potential confounders via fixed effects. The analysis was carried out using the pedigreemm package of R.
The second category involved the significant cis-eQTL, released from GTEx (version 6 in 2015) 67 . The expression data from GTEx involve multiple tissues from 449 individuals of mostly (> 80%) European ancestry. We used the cis eQTL results evaluated in 338 blood samples. The downloaded cis-eQTL results only list significant results (FDR q < 0.05), according to a permutation test based threshold that corrected for multiple comparisons across genes and tissue types. The third category involved the cis-eQTL results from LSMeta 68 , which was a large-scale eQTL meta-analysis in 5,331 blood samples collected from 7 studies including our study cohort inChianti. We downloaded the cis-eQTL results from http://genenetwork.nl/bloodeqtlbrowser/.
The fourth and fifth categories were discovery and replication samples from an eQTL analysis in peripheral blood 69 , respectively. The publicly released cis-eQTL results only involved the 9,640 most significant (FDR q < 0.01) cis-eQTL results (corresponding to 9,640 significant genes) from the discovery sample. The fourth category involved the expression data of 2,494 twins from the NTR cohort. The fifth category involved 1,895 unrelated individuals from the NESDA cohort.
For all five categories of blood data, the cis-window surrounding each SNP marker was defined as ±1 Mb. We defined a significant cis-eQTL relationship by imposing the following criteria: a) FDR q < 0.05 for categories 1 -3, b) FDR q < 0.01 for categories 4 & 5.
SMR analysis
SMR 22 uses SNPs as instrumental variables to test for a direct association between an exposure variable and an outcome variable, irrespective of potential confounders. Unlike conventional Mendelian randomization analysis, the SMR test uses summary-level data for both SNPexposure and SNP-outcome that can come from different GWAS studies 22 . We tested the expression levels of the eleven candidate genes identified in our leucocyte cis-eQTL analysis.
SMR defines a pleiotropic association as association between gene expression and a test trait due
to pleiotropy or causality ( Supplementary Fig. 11a-b Fig. 11c) .
To test the association of a given gene expression with age acceleration, we used summary level cis-eQTL results from (1) FHS, (2) GTEx and (3) LSMeta (total: N=10,906).
We included the cis SNPs (with MAF ≥ 0.10) within a test gene (± 1Mb). We selected the cis ) test statistic threshold of 10 for SNP pruning. The GWAS summary data were based on the meta-analysis results at the combined stage. As a sensitivity check, we repeated the HEIDI analysis using the summary GWAS data of individuals with European ancestry (studies 1-11).
Telomere length association studies for Mendelian randomization analysis
We gathered the summary statistics from three large-scale meta-analysis studies for association with LTL, including (I) the association results of 484 SNPs located in TERT locus listed in Supplementary Info from the study conducted by Bojesen et al. 24 Figure 3b .
IEAA association in brain tissues
To study the generalization of the overlap between telomere association and IEAA association in non-blood tissues, we used the GWAS results of IEAA in brain tissues from our recent studies including brain regions in cerebellum (N=555) 18 , in prefrontal cortex (N=657) 70 and in multiple areas across cerebellum, frontal cortex, pons, temporal cortex and prefrontal cortex (N=1,796 brain tissues) 70 . All the study populations were of European ancestry. All the IEAA measures were derived from Horvath DNAm Age. But, strictly speaking, the measure variable of age acceleration in cerebellum was simply based on the residuals from regression DNAm Age on chronological age only, referred as to AgeAccelerationResidual which is subtly distinct from IEAA.
In vitro studies of hTERT in human fibroblasts
Foreskins were obtained from routine elective circumcision. The tissue was cut into small pieces and digested overnight at 4C with Liberase, after which the epidermis was peeled away from the dermis. Several of dermis were placed face down in a plastic dish with DMEM supplemented with 10% foetal calf serum, penicillin, streptomycin and gentamycin. After incubation at 37oC with 5% carbon dioxide for a week, fibroblasts that emerged from the tissues were harvested and expanded in fresh vessels.
Recombinant retroviruses bearing the hTERT gene (pBabePurohTERT) or empty vector
(pBabePuro) were prepared by transfecting Phoenix A cells, recovering the recombinant viruses in the media and using them to infect primary fibroblasts. Following selection with 1ug/ml puromycin, surviving cells were used in the experiment described.
GWAS based enrichment analysis with MAGENTA
We used the MAGENTA software 28 to assess whether our meta-analysis GWAS results of epigenetic age acceleration are enriched for various gene sets, e.g. KEGG pathways, Gene Ontology (GO) terms such as biological processes or molecular functions. To assign genes to SNPs, we extended gene boundaries to +/-50kb. For computational reasons, we removed categories that did not contain any genes related to age acceleration at a level of P<1.0x10 -3 or that contained fewer than 10 genes. The cutoffs of gene set enrichment analysis (GSEA) in the MAGENTA algorithm were set at 95 th and 75 th percentiles which are the default parameter values for a general phenotype and for a highly polygenic trait, respectively 28 .
Initially, empirical P values were estimated based on 10,000 permutations. For significant gene sets (empirical P < 1.0x10 -4 ), we estimated the final empirical P value using one million permutations. We only report gene sets whose false discovery rate FDR (calculated by MAGENTA) was less than 0.20.
LDSC genetic correlation analysis
We performed cross-trait LD score regression 29 to relate IEAA/EEAA to various complex traits (27 GWAS summary data across 23 distinct phenotypes). The GWAS results for IEAA and EEAA were based on the summary data at stage 1 analysis.
The following is a terse description of the 27 published GWAS studies. Two GWAS results in individuals of European ancestry came from the GIANT consortium on body fat distribution:
waist circumference and hip to waist ratio. GWAS results of BMI and height also from the GIANT consortium. Further, we used published GWAS results from inflammatory bowel disorder (IBD) and its two subtypes: Crohn's disease and ulcerative colitis, lipid levels, metabolic outcomes and diseases: insulin and glucose levels, type 2 diabetes (stage 1 results) phenotype, age-related macular degeneration (neovascular and geographic atrophy), Alzheimer's disease (stage 1 results), attention deficit hyperactivity disorder (ADHD), bipolar disorder, major depressive disorder, schizophrenia, education attainment, age at menarche, age at menopause, LTL and longevity. The summary data of LTL was based the GWAS conducted by Codd et al 25 , as described in an earlier section. A description of other published GWAS study can be found in
Supplementary Note 4.
As recommend by LDSC, we filtered to HapMap3 SNPs for each GWAS summary data, which could help align allele codes of our GWAS results with other GWAS results for the genetic correlation analysis conducted. We constrained intercepts with the --intercept -h2 flag for the GWAS studies with GC-correction that we input the estimates of intercepts obtained from the heritability analysis implemented under LDSC.
MR-Egger regression
Under a weaker set of assumptions than typically used in Mendelian randomization (MR), an adaption of Egger regression can be used to detect and correct for the bias due to directional pleiotropy 27 . While the standard method of MR estimation, two-stage least squares, may be biased when directional pleiotropy is present, MR-Egger regression can provide a consistent estimate of the causal effect of an exposure (e.g. age at menopause) on an outcome trait (e.g. epigenetic age acceleration). In testing the regression model, we used the leading variants (P < 5.0x10 -8 or their surrogates) from each GWAS locus associated with the exposure, as instrumental variables. We performed LD-based clumping procedure in PLINK with a threshold of r 2 set at 0.1 in a window size of 250kb to yield the leading variants present in both GWAS summary data sets (for exposure and outcome), as needed. The random effects model metaanalysis was performed using "MendelianRandomization" R package.
GWAS-based overlap analysis between age acceleration and various phenotypes
Our GWAS-based overlap analysis related gene sets found by our GWAS of epigenetic age acceleration with analogous gene sets found by published GWAS of various phenotypes. We used the MAGENTA software to calculate an overall GWAS P value per gene, which is based on the most significant SNP association P value within the gene boundary (+/-50 kb) adjusted for gene size, number of SNPs per kb, and other potential confounders 28 . To assess the overlap between age acceleration and a test trait, we selected the top 2.5% (roughly 500 genes ranked by P values) and top 10 % genes (roughly 1900 genes) for each trait and calculated one-sided hypergeometric P values 18, 70 . In contrast with the genetic correlation analysis, GWAS based overlap analysis does not keep track of the signs of SNP allele associations.
We performed the overlap analysis for all the 23 complex traits used in the genetic correlation LDSC analysis and a few more studies that we were not able to conduct the LDSC analysis due to small sample size (N < 5000), negative heritability estimates or the entire study population from non-European ancestry. The additional traits including modifiers of Huntington's disease motor onset, Parkinson's disease and cognitive functioning traits (Supplementary note 4) . Adjusted epigenetic age of individual samples versus days in culture. The adjusted age estimate was defined as difference between DNAm age (Horvath method) minus 28 years, since the former exhibited a substantial offset in fibroblasts. 
Tables
Legend
Lead SNPs at genome-wide significant (P<5.0x10 -8 ) loci for IEAA or EEAA. Fixed effects meta-analysis was used to estimate the effect size (Beta) and standard error (SE) on IEAA or EEAA per minor allele. Trans-ethnic analyses using MANTRA 20 present ethnicity-adjusted associations (log 10 Bayes' Factor (BF) and probability of heterogeneity across studies (P HET. ). Bands corresponding the position of Meta GWAS SNP. *FDR > 0.05 but FDR < 0.05 associated with other GWAS SNPs ( Supplementary Table 6 ). a The SNP rs2341303 is a surrogate of the leading marker rs10937913 in 4p16.3 (LD ‫ݎ‬ ா ோ ଶ =.98). b The SMR results are derived from the same model as the analysis used the cis SNPs of the gene HSD17B7P2.
The table presents a total of six cis genes highlighted from transcriptomic study using three large-scale databases (N=10,906) including (1) FHS (N=5,257), (2) GTEx (N=338), and (3) LSMeta (5, 311) . Each cis gene exhibited significant cis-eQTL with several nearby GWAS SNPs at FDR q < 0.05 in at least one study and also showed a significant pleiotropic association in SMR analysis at P < 0.05 after Bonferroni correction. For each gene, we list the unadjusted P values (sign) from Meta GWAS for IEAA (or EEAA), cis-eQTL and SMR analysis. The column (sign) indicates the sign of Z statistic at each test while the test alleles were converted to the same alleles (with minor variants) for both Meta GWAS and cis-eQTL tests. The summary statistics of Meta GWAS and cis-eQTL are both based on the leading marker with the most significant P value in a given locus, according to the GWAS results. Units of the traits associated with quantitative measures are displayed within parentheses. P values < 0.05 marked in bold. AMD (subtype) = agerelated macular degeneration (geographic atrophy). 
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